• EdU Imaging Kits (488) for S-Phase Analysis

  2026-09-25

  EdU Imaging Kits (488) use 5-ethynyl-2'-deoxyuridine and click chemistry to label DNA synthesis during S phase without the harsh DNA denaturation used in traditional BrdU detection. The method offers a fluorescence-based cell proliferation assay for microscopy and flow cytometry; a preeclampsia study provides a relevant example of EdU use in umbilical cord mesenchymal stem cells.

• BQCA and the Translational Logic of M1 Signaling

  2026-09-25

  Benzyl Quinolone Carboxylic Acid (BQCA) offers a selective way to probe M1 muscarinic receptor signaling—but its value extends beyond potentiation alone. Recent GRK findings sharpen the experimental questions researchers should ask about pathway balance, assay context, and translation to cognitive models.

• Crystal Violet Staining Solution: Uses & Limits

  2026-09-24

  Crystal Violet Staining Solution is a 2% alkaline nuclear staining dye for visualizing cell nuclei and supporting cell-based assay workflows. Its product specifications do not establish a universal protocol or prove that every crystal violet biofilm assay result applies to this formulation.

• Disodium Bicinchoninate for Cell Assay Workflows

  2026-09-24

  Use Disodium bicinchoninate to support aqueous, copper-based protein quantification in cell and nanoparticle studies—without confusing an analytical reagent with a therapeutic treatment. This guide connects practical assay setup to an inflammatory granulosa-cell study and highlights matrix effects that can undermine protein normalization.

• Preeclampsia-Linked Abnormalities in Umbilical Cord MSCs

  2026-09-23

  This study links preeclampsia with reduced proliferation, senescence-associated features, mitochondrial impairment, and cytoskeletal abnormalities in umbilical cord mesenchymal stem cells. Its combined transcriptomic and cell-based analyses identify senescence as a potential research target, while leaving open whether these findings can be reversed or translated into clinical benefit.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-09-23

  A whole-genome CRISPR screen identified CLCC1 as a host factor required for the membrane-fusion step of herpesvirus nuclear egress. CLCC1 loss caused capsid-containing perinuclear vesicle accumulation, reduced viral production, and defective nuclear pore insertion, linking viral transport to broader nuclear-envelope morphogenesis.

• From Secretory Heterogeneity to Translational Design

  2026-09-22

  Single-cell secretion profiling is changing how researchers define potency in mesenchymal stromal cells. This article examines why VEGF-A secretion cannot be inferred reliably from transcript abundance alone, how SEC-seq can expose functional subpopulations, and how 4-Methoxychalcone-1 can be evaluated as a hypothesis-generating perturbation in a rigorous translational workflow.

• InstaBlue Protein Stain Solution for Mechanistic Workflows

  2026-09-22

  InstaBlue Protein Stain Solution connects rapid gel visualization with rigorous neuronal stress research. This guide explains how a Coomassie Brilliant Blue protein stain can support ferroptosis-focused protein electrophoresis analysis without being mistaken for mechanistic proof.

• JC-1 Maps Mitochondrial Risk in Bladder Cancer

  2026-09-21

  A translational framework for using mitochondrial membrane potential to connect LRG1-driven neutrophil dysfunction, NETosis, vascular pathology, and therapeutic response in bladder cancer research.

• Sodium chloride B7288: Buffer and QC Guide

  2026-09-21

  Sodium chloride B7288 is a water-soluble inorganic salt for adjusting ionic strength and osmotic balance in aqueous buffers, biochemical assays, and selected cell culture media workflows. This guide explains preparation, documentation, and QC boundaries while clarifying that it is not a pH buffer, a DMSO or ethanol stock, or a substitute for sterility-qualified material.

• BRCAness and Olaparib Sensitivity in Mesothelioma

  2026-09-20

  Borchert et al. linked homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma, with particular sensitivity observed in BAP1-mutated models. The study integrates cell-line treatment experiments with profiling of 91 clinical samples, providing a framework for biomarker-guided PARP-inhibitor research while highlighting the need for validation beyond in vitro systems.

• (-)-Blebbistatin for Cardiac Mechanics & Cell Assays

  2026-09-19

  (-)-Blebbistatin is a reversible, cell-permeable non-muscle myosin II inhibitor for separating actomyosin-dependent mechanics from electrical signaling, adhesion, migration, and contractility. Used alongside HCN4 temperature-response experiments, it helps distinguish changes in pacemaker excitability from changes in force generation without directly targeting HCN channels.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-09-18

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or polymerase-generated sticky ends.

• Caspase-3/NDUFS1 Axis in Trichothecene ROS

  2026-09-18

  This preprint identifies a mechanistic link between caspase-3 activation, cleavage of mitochondrial complex I subunit NDUFS1, and reactive oxygen species accumulation during DON- and T-2 toxin-induced liver injury. It also implicates ER-localized ERO1α as a parallel oxidative source, suggesting that mitochondrial and ER redox stress reinforce one another.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-09-17

  Greenwood and colleagues combine a human before-and-after study with rat pituitary proteomics, phosphoproteomics, an AVP secretion reporter assay, and renal signaling analysis to connect liraglutide with reduced vasopressin release. The work identifies time- and sex-dependent synaptic phosphorylation changes and downstream aquaporin 2 regulation, providing a mechanistic framework for the fluid, renal, and cardiovascular effects of GLP-1 receptor agonists.

8546 records 1/570 page Next 12345 下5页 Last page